The aging of neurons is a hallmark of getting older, but understanding which cells drive this process—and through which molecular signals—remains unclear. The mTOR protein is known to promote aging in various organisms, but scientists haven't been sure whether this happens because of mTOR activity within neurons themselves, in other brain cell types, or in the body's peripheral tissues. This distinction matters because it affects where to target drugs or interventions.
To tackle this question, the researchers used C. elegans (a 1-mm transparent worm commonly used in aging research) and engineered two experimental systems. First, they knocked down mTOR (called let-363 in worms) across the whole body in adult worms and measured lifespan and neuronal morphology. Second, they knocked down mTOR only within a specific subset of neurons—the Touch Receptor Neurons (ALM neurons)—and measured the same outcomes. This cell-type-specific approach is a strength because it isolates cause-and-effect within neurons.
They found that knocking down mTOR across the whole body did little to prevent aging or change lifespan. However, turning off mTOR specifically within neurons reduced ectopic neurite sprouting—the abnormal, unwanted growth of branch-like extensions from the nerve cell body that accumulates with age. This reduction occurred without extending the worms' total lifespan, suggesting mTOR influences specific aspects of neuronal aging rather than driving aging broadly.
Several limitations constrain the impact of these findings. First, this is a single-organism study in C. elegans; whether mTOR functions the same way in mammalian neurons remains untested. Second, they only examined one neuron type (touch receptors); mTOR may operate differently in other neurons. Third, and importantly, they did not extend lifespan, meaning the morphological improvements may not translate to functional benefits or increased longevity. Fourth, the paper doesn't explore the downstream mechanisms—what is mTOR actually doing inside neurons to trigger sprouting?
These results refine our understanding of mTOR's role in neuronal aging by showing cell-type specificity: mTOR's effects on neuronal morphology appear to be intrinsic to neurons rather than systemic. This is conceptually important because it suggests targeting neuronal mTOR might improve neuronal structure without affecting whole-body aging processes. However, the lack of lifespan extension and the narrow focus on morphology rather than neuronal function mean this finding is more foundational than immediately applicable to human longevity.
For the longevity field, this work is a solid mechanistic stepping stone. It clarifies where mTOR acts, but future studies must test whether improving neuronal morphology in mammals translates to better neuronal function, healthspan, or lifespan—and whether mTOR inhibition in the brain alone is sufficient to produce benefits.
0 Comments
Log in to join the discussion.